概要
Click Here to View the Program in Japanese
プログラム委員会
-
Goshi Ozawa, MS CEO
Real Discovery Outdorrs K.K., Japan -
Noriaki Nagao, MPHARM, PMP Pharmaceutical Division,Clinical Development Dept.
JAPAN TOBACCO INC., Japan -
Toshinori Higashi, PHD Vice President, Regulatory Science
KAKEN PHARMACEUTICAL CO.,LTD., Japan -
Naoki Isogawa, PHD Biometrics & Quantitative Sciences East Asia (BQS), Head of BQS East Asia
UCB Japan Co., Ltd., Japan -
Yuu Jincho, JD, MSC Clinical Operation & Platforms /Data Management & Strategy
GlaxoSmithKline K.K., Japan -
Keiko Katsui, PHD Division of Biomedical Ethics and Social Co-Creation
Japan Agency for Medical Research and Development (AMED), Japan -
Kentaro Kogushi, PHD Head of Clinical Development Neurology-Psychiatry, Japan Development
AbbVie GK, Japan -
Mika Maeda Lecturer, Section for Human Research Protections, Kitasato University Hospital
School of Pharmacy, Kitasato University, Japan -
Kana Maruyama Manager, Regulatory Labeling, Regulatory Affairs
Viatris Pharmaceuticals Japan GK, Japan -
Yukihiro Matsuda, MSC Director of Project Management
Linical Japan, Japan -
Kotone Matsuyama, RPH Center for Clinical Research and Development
National Center for Child Health and Development, Japan -
So Miyoshi Head of Clinical Pharmacology & Bioanalytics
Pfizer R&D Japan, Japan -
Hiroyuki Murakami, PHD Duputy Review Director, Office of New Drug I
Pharmaceuticals and Medical Devices Agency (PMDA), Japan -
Makoto Nagaoka, PHD Senior Director, Global Regulatory Affairs Strategy, Consulting
Fortrea Japan K.K., Japan -
Keisuke Suzuki, PHD Director, Innovation Center for Translational Research
National Center for Geriatrics and Gerontology, Japan -
Tomohiko Takahashi Associate Manager, Headquarters of Clinical Development
Otsuka Pharmaceutical Co., Ltd., Japan -
Keiko Tsumori, MSC Associate Principle Scientist, Medical Writing, Regulatory Affairs Area, Japan D
MSD K.K., Japan -
Tadashi Urashima, PHD Performance and Digital Analytics Lead, Japan Development
GlaxoSmithKline K.K., Japan
